Intensity Therapeutics, Inc Common stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $-26 | $0 | $0 | $0 |
Gross Profit | -7 | -6 | -7 | -6 |
EBITDA | -3,134 | 62 | -2,705 | -3,394 |
EBIT | -3,141 | -2,671 | -2,537 | -3,400 |
Net Income | -3,051 | -2,671 | -2,537 | -3,347 |
Net Change In Cash | -26 | 0 | 0 | 0 |
Free Cash Flow | -2,401 | -2,387 | -2,456 | -1,989 |
Cash | 11,921 | 7,067 | 2,216 | 929 |
Basic Shares | 13,563 | 1,721 | 754 | 606 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -26 | -25 | -147 | -179 |
EBITDA | -11,972 | -16,268 | -10,086 | -7,500 |
EBIT | -16,268 | -10,233 | -7,581 | |
Net Income | -11,606 | -16,268 | -10,538 | -7,582 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,233 | -15,220 | -7,205 | -5,477 |
Cash | 11,921 | 2,590 | 8,556 | 1,312 |
Basic Shares | 13,563 | 556 | 344 | 136 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$1.20 |
2025-09-30 | -$0.06 |
2025-06-30 | -$0.13 |
